ABOUT THIS EPISODE
Prof Razelle Kurzrock - University of California, San Diego, USA
Dr Kurzrock talks to ecancertv at WIN 2015 about the SPRING trial, one of the next set of trials being planned by the WIN Consortium following on from the seminal WINTHER study.
In this SPRING trial, advanced genomic profiling will be used to help guide second-line therapy for patients with metastatic nonsmall-cell lung cancer which will consist of a combination of three of the most appropriately targeted drugs.
Dr Kurzrock talks to ecancertv at WIN 2015 about the SPRING trial, one of the next set of trials being planned by the WIN Consortium following on from the seminal WINTHER study.
In this SPRING trial, advanced genomic profiling will be used to help guide second-line therapy for patients with metastatic nonsmall-cell lung cancer which will consist of a combination of three of the most appropriately targeted drugs.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
Dr Harvey Pass - New York University Langone Medical Center, New York, USA
Dr Pass talks to ecancertv at WIN 2015 about the WIN Consortium’s BOOSTER initiative.
BOOSTER is a research programme being designed to help with the discovery and validation of new blood biomarkers for the diagnosis of ea…
Dr Stanley Hamilton - MD Anderson Cancer Centre, Houston, USA
Dr Hamilton talks to ecancertv at WIN 2015 about his presentation on the need for methodology certification and accreditations to perform assays in the US.
In the interview he talks about some of the issues of conducting clinical trial…
Dr Andrea Califano, Columbia University Department of Systems Biology, New York, USA
Dr Califano talks to ecancer at the WIN Symposium 2015 about his keynote lecture on using a systems biology approach to precision cancer medicine.
In the interview, Dr Califano discusses current research being pe…
Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO)
Dr Richard Schilsky, Chief Medical Officer of the American Society of Oncology (ASCO) and chairman of the WIN Consortium Scientific Advisory Board, provides ecancertv with an overview of a roundtable session h…
Disclaimer: The podcast and artwork embedded on this page are from ecancer.org, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
